Great news from Array Biopharma (NASDAQ: ARRY) re: Phase II results from the ARRY-797 asset, a small molecule p38-alpha inhibitor which modulates the production of TNF, IL-1 and IL-6 inflammatory mediators and the PGE2 pain mediator. The post-surgical molar extraction dental pain study achieved all of its total pain relief endpoints for analgesic efficacy. ARRY-797 [...]

• 337http://clsdf.com/2008/03/arry-797-analgesic-effect-check/ARRY-797%3A+Analgesic+Effect%3F+Check%212008-03-05+15%3A42%3A00admin

For the first time in years, say since undergrad, I sat down and consumed an entire book, cover-to-cover in a single sitting. It was Valley Boy: The Education of Tom Perkins that sucked me in on a snowy Sunday. Tom Perkins helped to pioneer the innovation center that is Silicon Valley, first at Hewlett Packard [...]

• 336http://clsdf.com/2008/03/valley-boy-the-education-of-me/Valley+Boy...The+Education+of+Me2008-03-05+15%3A35%3A00admin